549835
2,4,6-Tris(dimethylamino)-1,3,5-triazine
96%
Synonym(s):
Altretamine, Hexamethylmelamine
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C9H18N6
CAS Number:
Molecular Weight:
210.28
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Quality Level
Assay
96%
mp
171-175 °C (lit.)
functional group
amine
SMILES string
CN(C)c1nc(nc(n1)N(C)C)N(C)C
InChI
1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3
InChI key
UUVWYPNAQBNQJQ-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
2,4,6-Tris(dimethylamino)-1,3,5-triazine exhibits antitumor activity.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Triazines and related products. Part 26. Synthesis and chemistry of bicyclic analogues of the antitumour drug 2, 4, 6-tris (dimethylamino)-1, 3, 5-triazine (hexamethylmelamine).
Langdon SP, et al.
Journal of the Chemical Society. Perkin Transactions 1, 993-998 (1984)
Rafael Samper-Ternent et al.
Journal of the American Geriatrics Society, 56(10), 1845-1852 (2008-09-25)
To examine the association between frailty status and change in cognitive function over time in older Mexican Americans. Data used were from the Hispanic Established Population for the Epidemiological Study of the Elderly. Five southwestern states: Texas, New Mexico, Colorado
I Olver et al.
Cancer chemotherapy and pharmacology, 48(2), 109-114 (2001-09-20)
The efficacy and pharmacokinetics of paclitaxel when combined with altretamine for ovarian cancer were studied. A group of 30 patients, whose only chemotherapy was one or more cisplatin-based non-paclitaxel-containing regimens and whose ovarian cancer failed to respond or had relapsed
Better treatments improve survival of CHD patients.
Loretta Ninivaggi
The Nurse practitioner, 30(9), 57-63 (2005-09-10)
Thomas J Herzog
Clinical cancer research : an official journal of the American Association for Cancer Research, 10(22), 7439-7449 (2004-12-01)
Ovarian cancer is increasingly recognized as a chronic disease whose treatment is often characterized by administration of multiple, sequential active agents, each of which may or may not be accompanied by a tumor response. Despite the large proportion of patients
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service